These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparative bioactivity of atrial and brain natriuretic peptides in an ovine model of heart failure. Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM Clin Sci (Lond); 1997 Feb; 92(2):159-65. PubMed ID: 9059317 [TBL] [Abstract][Full Text] [Related]
4. Effects of natriuretic peptides on load and myocardial function in normal and heart failure dogs. Lainchbury JG; Burnett JC; Meyer D; Redfield MM Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H33-40. PubMed ID: 10644581 [TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects. Cargill RI; Lipworth BJ Chest; 1996 Nov; 110(5):1220-5. PubMed ID: 8915224 [TBL] [Abstract][Full Text] [Related]
6. Chronic infusions of brain natriuretic peptide in conscious sheep: bioactivity at low physiological levels. Charles CJ; Espiner EA; Nicholls MG; Rademaker MT; Richards AM Clin Sci (Lond); 1998 Dec; 95(6):701-8. PubMed ID: 9831695 [TBL] [Abstract][Full Text] [Related]
7. Equimolar doses of atrial and brain natriuretic peptides and urodilatin have differential renal actions in overt experimental heart failure. Chen HH; Cataliotti A; Schirger JA; Martin FL; Burnett JC Am J Physiol Regul Integr Comp Physiol; 2005 May; 288(5):R1093-7. PubMed ID: 15627648 [TBL] [Abstract][Full Text] [Related]
8. Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin. Kamijo T; Kamei K; Sugo I; Kamiyama T; Sudo H; Ohba Y J Cardiovasc Pharmacol; 1999 Jan; 33(1):93-101. PubMed ID: 9890402 [TBL] [Abstract][Full Text] [Related]
9. Vascular effects of natriuretic peptides in healthy men. Komarek M; Bernheim A; Schindler R; Steden R; Kiowski W; Brunner-La Rocca HP J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):263-70. PubMed ID: 15678245 [TBL] [Abstract][Full Text] [Related]
10. Role of endogenous atrial natriuretic peptide in DOCA-salt hypertensive rats. Effects of a novel nonpeptide antagonist for atrial natriuretic peptide receptor. Hirata Y; Matsuoka H; Suzuki E; Hayakawa H; Sugimoto T; Matsuda Y; Morishita Y; Kangawa K; Minamino N; Matsuo H Circulation; 1993 Feb; 87(2):554-61. PubMed ID: 8381060 [TBL] [Abstract][Full Text] [Related]
11. Bioactivity of natriuretic peptide coinfusions; no evidence for unique effects of BNP in conscious sheep. Charles CJ; Espiner EA; Nicholls MG; Rademaker MT; Richards AM J Cardiovasc Pharmacol; 1999 Feb; 33(2):229-36. PubMed ID: 10028930 [TBL] [Abstract][Full Text] [Related]
12. Differing biological effects of equimolar atrial and brain natriuretic peptide infusions in normal man. Hunt PJ; Espiner EA; Nicholls MG; Richards AM; Yandle TG J Clin Endocrinol Metab; 1996 Nov; 81(11):3871-6. PubMed ID: 8923831 [TBL] [Abstract][Full Text] [Related]
13. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure. Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734 [TBL] [Abstract][Full Text] [Related]
14. Contrasting cardiac regional responses of A-type and B-type natriuretic peptide to experimental chronic heart failure. Hystad ME; Klinge R; Spurkland A; Attramadal H; Hall C Scand J Clin Lab Invest; 2000 Jul; 60(4):299-309. PubMed ID: 10943600 [TBL] [Abstract][Full Text] [Related]
15. Natriuretic peptide responses to acute and chronic ventricular pacing in sheep. Rademaker MT; Charles CJ; Espiner EA; Frampton CM; Nicholls MG; Richards AM Am J Physiol; 1996 Feb; 270(2 Pt 2):H594-602. PubMed ID: 8779835 [TBL] [Abstract][Full Text] [Related]
16. Slower onset of vasodilating action of brain natriuretic peptide (BNP) compared to atrial natriuretic peptide (ANP) in human forearm resistant vessels. Minami H; Yasu T; Tagawa T; Yamakawa K; Ueda S Eur J Clin Pharmacol; 2008 Sep; 64(9):859-62. PubMed ID: 18622600 [TBL] [Abstract][Full Text] [Related]
17. Effects of brain natriuretic peptide on hemodynamics and renal function in dogs. Nishida Y; Morita H; Minamino N; Kangawa K; Matsuo H; Hosomi H Jpn J Physiol; 1990; 40(4):531-40. PubMed ID: 2150207 [TBL] [Abstract][Full Text] [Related]
18. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot. Hayabuchi Y; Matsuoka S; Kuroda Y Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688 [TBL] [Abstract][Full Text] [Related]
19. Vasorelaxing effects of atrial and brain natriuretic peptides on coronary circulation in heart failure. Matsumoto T; Wada A; Tsutamoto T; Omura T; Yokohama H; Ohnishi M; Nakae I; Takahashi M; Kinoshita M Am J Physiol; 1999 Jun; 276(6):H1935-42. PubMed ID: 10362673 [TBL] [Abstract][Full Text] [Related]
20. Interactions of atrial and brain natriuretic peptides at pathophysiological levels in normal men. Hunt PJ; Espiner EA; Richards AM; Yandle TG; Frampton C; Nicholls MG Am J Physiol; 1995 Dec; 269(6 Pt 2):R1397-403. PubMed ID: 8594942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]